Refreshed just now
BeOne, Hengrui top list of China’s most powerful drugmakers
Why it’s here: Covers China's biotech competition with a live US policy fight over the COINS outbound investment law and proposed limits on US deals with Chinese drugmakers, which falls within the Biotechnology area's BIOSECURE/China competition scope.
Trace across the boardItem
6d agoSTATBeOne, Hengrui top list of China’s most powerful drugmakersSTAT and WireScreen released a quarterly ranking of China's 25 most valuable novel-medicine developers, led by BeOne Medicines and Jiangsu Hengrui.1 outlet2 linked
Connected
2 links- NewsFormer Sen. Roy Blunt: Trump’s latest China crackdown puts American lives on the lineBoth involve COINS Act, Comprehensive Outbound Investment National Security (COINS) Act
- NewsHow Democrats’ midterm sweep will rewire energy and data center policyBoth involve Trump administration, David Crowley
About
- Trump administration
- COINS Act